Banco Santander Sa (SAN)

Trade SAN now with
11/11/2022 7:00:59 AM Regeneron Pharma And Sanofi Announce Dupixent Recommended For EU Approval By The CHMP For Prurigo Nodularis
10/26/2022 12:59:36 AM Santander Reports 9-month Attributable Profit Of EUR 7.316 Bln
10/11/2022 1:02:13 AM Regeneron : Dupixent Phase 3 Data Show Significant Histological Remission Of Eosinophilic Esophagitis In Children
8/26/2022 8:03:11 AM Sanofi Says Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity &Mortality Weekly Report
7/28/2022 3:06:44 AM Banco Santander H1 Earnings Rise
7/28/2022 1:55:43 AM Banco Santander H1 Underlying Profit EUR 4.894 Bln, Up 16% In Current Euros Versus Last Year
6/17/2022 2:14:16 AM Banco Santander Says Héctor Grisi Nominated To Succeed José Antonio Álvarez As CEO
6/7/2022 8:34:15 AM Sanofi Announces Opening Of New Campus At Cambridge Crossing In Cambridge, Massachusetts
5/31/2022 1:05:43 AM Regeneron Pharma: FDA Accepts Dupixent For Priority Review In Adults With Prurigo Nodularis
4/26/2022 1:30:26 AM Banco Santander Q1 EPS EUR 0.141 Vs EUR 0.085 Last Year
4/7/2022 1:01:23 AM Regeneron Pharma And Sanofi: EC Expands Marketing Authorization For Dupixent In The European Union
3/28/2022 8:04:14 AM Sanofi : Canada Oks Dupixent To Treat Severe Asthma In Children Aged Six To 11 Years With Type 2 Inflammation
3/16/2022 6:36:51 AM Seagen And Sanofi Collaborate To Commercialize Multiple Novel Antibody-Drug Conjugates For Up To Three Cancer Targets
2/2/2022 1:10:56 AM Banco Santander Q4 Attributable Profit To The Parent EUR 2.275 Bln, Up 4.6% Q/Q
1/21/2022 8:06:27 AM Santander Announces Extension Of Tender Offer For Santander Consumer USA Until January 27